According to recent diabetes research at the University of Leicester, a new advance in studying a protein and fatty acids could open up a major new diabetes drug target.
The breakthrough, which the researchers described as ‘very significant’, could result in new drugs being created to help target a protein that fundamentally influences how the body breaks down sugar .
A team from the university of Leicester department of biochemisty, alongside other researchers from Japan and Hungary, studied protein PPAR gamma. The team used a sophisticated new method called X-ray Crystallography. The technique fires X-rays at the target.
The team reportedly commented: "The finding that natural activators for PPAR gamma couple irreversibly to the PPAR gamma receptor dramatically changes our understanding of how this receptor is activated. It may also allow for the design of novel pharmaceuticals that give longer term activation of PPAR gamma, at lower doses, without some of the side effects of the current generation of drugs."
New diabetes drug target
Fri, 26 Sep 2008
Recommended links
Diabetes newsletterDiabetes based financial services
Diabetes forum
Diabetes signs and symptoms
Female diabetes and low bone density
New diabetes treatment hope
Diabetes Sufferrers Blood Pressure Lowered
Umbilical cord blood has powerful diabetes influence
Lifescan warns Diabetes Sufferers Worldwide of Potential Problem with Its Blood Glucose Meters
New diabetes drug controls blood sugar and weight
Gator blood protein could have role in treating diabetes ulcers
Diabetes blood glucose meters warning
Amylin diabetes drug lowers blood sugar level
Diabetes sufferers benefit from blood pressure medicine
Normal Blood Sugar Does Not Mean No Diabetes
Early blood glucose control in diabetes positive
Blood pressure drugs lower diabetes in Hispanics
Obesity and diabetes risk linked to maternal blood sugar level
Diabetes risk cut by blood pressure drug
Biotech v big pharma
Pharmaceutical firm buys Japanese diabetes drug
